Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

RAIN

Rain Oncology (RAIN)

Rain Oncology Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RAIN
DateHeureSourceTitreSymboleSociété
05/02/202412h41Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RAINRain Oncology Inc
31/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RAINRain Oncology Inc
26/01/202422h58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
26/01/202422h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
26/01/202422h32Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RAINRain Oncology Inc
26/01/202415h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
26/01/202415h19Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
26/01/202415h13Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
03/01/202420h57PR Newswire (US)Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law FirmNASDAQ:RAINRain Oncology Inc
27/12/202315h27Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RAINRain Oncology Inc
27/12/202315h20Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:RAINRain Oncology Inc
14/12/202312h06Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:RAINRain Oncology Inc
09/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAINRain Oncology Inc
12/09/202311h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
11/08/202311h45PR Newswire (US)RAIN SHAREHOLDER ALERT: Jakubowitz Law Reminds Rain Shareholders of a Lead Plaintiff Deadline of September 12, 2023NASDAQ:RAINRain Oncology Inc
06/07/202311h45PR Newswire (US)INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
30/06/202311h45PR Newswire (US)RAIN FRAUD ALERT: Jakubowitz Law is Investigating Rain Oncology Inc. in Connection with Potential Violations of Federal Securities LawsNASDAQ:RAINRain Oncology Inc
10/03/202323h22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RAINRain Oncology Inc
09/03/202322h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RAINRain Oncology Inc
03/03/202323h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RAINRain Oncology Inc
14/02/202323h22Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RAINRain Oncology Inc
14/02/202321h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RAINRain Oncology Inc
18/11/202218h35TipRanksJonesTrading Reaffirms Their Buy Rating on Rain Therapeutics (RAIN)NASDAQ:RAINRain Oncology Inc
11/11/202217h25TipRanksJonesTrading Keeps Their Buy Rating on Rain Therapeutics (RAIN)NASDAQ:RAINRain Oncology Inc
10/11/202222h52Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RAINRain Oncology Inc
10/11/202222h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RAINRain Oncology Inc
04/11/202213h00GlobeNewswire Inc.Rain Therapeutics Announces $50 Million Registered Offering of Common StockNASDAQ:RAINRain Oncology Inc
04/11/202211h07Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:RAINRain Oncology Inc
20/09/202214h25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Rain Therapeutics (RAIN)NASDAQ:RAINRain Oncology Inc
12/09/202214h15TipRanksRain Therapeutics (RAIN) Gets a Buy from JonesTradingNASDAQ:RAINRain Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:RAIN

Dernières Valeurs Consultées